Kimchi friend or foe: preserving cultural foods developed pre-refrigeration.
사설/논평
1/5 보강
[OBJECTIVE] In this commentary, we examine whether kimchi acts primarily as a risk factor or a protective dietary component for gastric cancer.
APA
Yang JY, Kim KE, et al. (2026). Kimchi friend or foe: preserving cultural foods developed pre-refrigeration.. Preventive medicine reports, 61, 103357. https://doi.org/10.1016/j.pmedr.2025.103357
MLA
Yang JY, et al.. "Kimchi friend or foe: preserving cultural foods developed pre-refrigeration.." Preventive medicine reports, vol. 61, 2026, pp. 103357.
PMID
41560871
Abstract
[OBJECTIVE] In this commentary, we examine whether kimchi acts primarily as a risk factor or a protective dietary component for gastric cancer.
[METHODS] By breaking kimchi down into individual ingredients, we summarize evidence on the potential protective and carcinogenic effects.
[RESULTS] Epidemiologic findings on kimchi and gastric cancer remain inconsistent, likely due to variation in sodium content, fermentation practices, and overall dietary patterns.
[CONCLUSIONS] We propose that reducing sodium content while preserving traditional fermentation methods may enhance the health benefits of kimchi while lowering preventable cancer risk. This commentary highlights the importance of culturally informed dietary strategies for gastric cancer prevention.
[METHODS] By breaking kimchi down into individual ingredients, we summarize evidence on the potential protective and carcinogenic effects.
[RESULTS] Epidemiologic findings on kimchi and gastric cancer remain inconsistent, likely due to variation in sodium content, fermentation practices, and overall dietary patterns.
[CONCLUSIONS] We propose that reducing sodium content while preserving traditional fermentation methods may enhance the health benefits of kimchi while lowering preventable cancer risk. This commentary highlights the importance of culturally informed dietary strategies for gastric cancer prevention.
같은 제1저자의 인용 많은 논문 (5)
- Upper Endoscopy Is Associated With Reduced Gastric Cancer-Specific and Overall Mortality in Patients Undergoing Colonoscopy or Sigmoidoscopy.
- GFAT1 promotes the progression of hepatocellular carcinoma via enhancing the O-GlcNAcylation of VEZF1.
- Quality of life after chemotherapy for advanced gastric cancer: S-1 vs. XELOX at 1 year after treatment.
- Sequential treatment from mandibulectomy to reconstruction on mandibular oral cancer - Case review II: mandibular anterior and the floor of the mouth lesion of basaloid squamous cell carcinoma and clear cell odontogenic carcinoma.
- [Evaluation of profile aesthetics of skeletal Class Ⅱ patients with different treatment methods].